- This event has passed.
38th Annual CFS®: Innovative Cancer Therapy for Tomorrow®
November 4, 2020 @ 8:00 am - November 6, 2020 @ 5:00 pm
USD $59938th Annual Chemotherapy Foundation Symposium Overview
Exciting new breakthroughs and rapid changes continue to occur in the management of solid and hematologic malignancies. Just this past year, practice-changing diagnostic, therapeutic, and supportive care strategies have entered clinical practice, and many more are poised to enter the field. The application of optimized testing approaches, locoregional and systemic therapies, including the use of chemotherapies, targeted therapies, immunotherapies, alone and in combination, along with multimodal strategies, continue to drive improved outcomes across multiple lines of care. Critical knowledge, competence, and performance gaps among practitioners must be addressed to ensure that these approaches are effectively and safely integrated into professional practice.
Each year, the Chemotherapy Foundation Symposium® (CFS®), brings together more than 2000 healthcare professionals for 3 days, with the aim of promoting the delivery of evidence-based, state-of-the-art cancer care for both routine and the most challenging clinical scenarios. At the 38th Annual CFS®, our internationally renowned faculty will provide you with expert insights on the latest developments in cancer therapeutics, offering an unparalleled opportunity to learn how innovative approaches fit into existing treatment paradigms to optimize care and outcomes for your patients with cancer.
Benefits of Attending
- Incorporate the latest clinical data and evidence-based strategies into your practice
- Learn experts’ viewpoints on areas of clinical uncertainty
- Network with the top minds in oncology
- 100 Experts. 25 Tumor Types. 3 Days. 1 Meeting. Something for everyone!
Target Audience
This educational activity is directed toward oncologists, hematologists, nurses, nurse practitioners, and pharmacists involved in the treatment/management of patients with cancer. Radiotherapists, immunologists, fellows, physician assistants, researchers, case managers, and other healthcare professionals interested in the treatment of cancer are also invited to attend.
